Quince Therapeutics (QNCX) Institutional Ownership $1.03 +0.01 (+0.98%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.00 -0.03 (-3.30%) As of 05/21/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Quince Therapeutics (NASDAQ:QNCX)CurrentInstitutional OwnershipPercentage30.75%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$1.84MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$27.15K Get QNCX Insider Trade Alerts Want to know when executives and insiders are buying or selling Quince Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data QNCX Institutional Buying and Selling by Quarter Quince Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025 Ieq Capital LLC806,780$1.07M0.0%N/A1.828% 5/12/2025 Virtu Financial LLC43,332$58K0.0%+48.4%0.098% 4/11/2025 Intellectus Partners LLC53,312$71K0.0%N/A0.121% 2/17/2025 Two Sigma Investments LP30,341$57K0.0%N/A0.069% 2/17/2025 Shay Capital LLC276,799$518K0.1%+60.8%0.629% 2/14/2025 Northern Trust Corp50,524$94K0.0%+48.5%0.115% 2/12/2025 Geode Capital Management LLC375,932$703K0.0%+10.9%0.854% 2/11/2025 Virtu Financial LLC29,204$55K0.0%N/A0.066% 2/5/2025 Anfield Capital Management LLC26,656$50K0.0%N/A0.061% 1/24/2025 Scharf Investments LLC91,061$170K0.0%N/A0.207% 11/16/2024 Geode Capital Management LLC339,125$263K0.0%+24.2%0.784% 8/9/2024 Renaissance Technologies LLC483,902$363K0.0%-7.0%1.120% 1/12/2024 Scharf Investments LLC91,061$96K0.0%N/A0.212% 7/31/2023 Intellectus Partners LLC53,527$81K0.0%N/A0.148% 7/24/2023 BML Capital Management LLC1,411,839$2.13M1.9%N/A3.892% 5/11/2023EPIQ Capital Group LLC958,469$1.50M0.8%-9.3%2.642% 4/20/2023 Hennion & Walsh Asset Management Inc.31,061$48K0.0%N/A0.086% (Data available from 1/1/2016 forward) QNCX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of QNCX shares? During the previous two years, 11 institutional investors and hedge funds held shares of Quince Therapeutics. The most heavily invested institutionals were BML Capital Management LLC ($2.13M), Ieq Capital LLC ($1.07M), Geode Capital Management LLC ($703K), Shay Capital LLC ($518K), Renaissance Technologies LLC ($363K), Scharf Investments LLC ($170K), and Northern Trust Corp ($94K).Learn more on QNCX's institutional investors. What percentage of Quince Therapeutics stock is owned by institutional investors? 30.75% of Quince Therapeutics stock is owned by institutional investors. Learn more on QNCX's institutional investor holdings. Which institutional investors have been buying Quince Therapeutics stock? Of the 10 institutional investors that purchased Quince Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($1.41M), Ieq Capital LLC ($806.78K), Scharf Investments LLC ($182.12K), Intellectus Partners LLC ($106.84K), Shay Capital LLC ($104.62K), Geode Capital Management LLC ($102.98K), and Virtu Financial LLC ($43.33K). How much institutional buying is happening at Quince Therapeutics? Institutional investors have bought a total of 2,832,003 shares in the last 24 months. This purchase volume represents approximately $4.14M in transactions. Which Quince Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Quince Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($36.20K). How much institutional selling is happening at Quince Therapeutics? Institutional investors have sold a total of 36,198 shares in the last 24 months. This volume of shares sold represents approximately $27.15K in transactions. Related Companies Prime Medicine Major Shareholders INmune Bio Major Shareholders Tiziana Life Sciences Major Shareholders Molecular Partners Major Shareholders Eledon Pharmaceuticals Major Shareholders CytomX Therapeutics Major Shareholders Organigram Major Shareholders Inhibrx Major Shareholders ProQR Therapeutics Major Shareholders TuHURA Biosciences Major Shareholders This page (NASDAQ:QNCX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quince Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quince Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy QNCX Stock Free QNCX Stock Alerts